Annie Luetkemeyer, MD, professor of infectious diseases at UCSF, is an expert on the treatment of viral infections. Robert Wachter, MD, MHM, chair of the UCSF Department of Medicine, interviewed her about the evidence behind potential treatments for COVID-19 (including chloroquine/hydroxychloroquine, remdesivir, and others), as well as how to assess new and existing drugs in a pandemic.
Clinical
Treatment options for COVID-19: Dr. Annie Luetkemeyer
Next Article:
Comments ()
Clinical
-
Consensus document reviews determination of brain death -
-
-
-
-
-
Hypertension often goes undertreated in patients with a history of stroke -
Studies gauge role of schools, kids in spread of COVID-19 -
Guidance covers glycemia in dexamethasone-treated COVID-19 patients -
Quality
-
-
-
-
-
Public Policy
-
-
Schools can reopen safely with precautions, experts say -
-
-
Practice Management
-
-
-
-
US News releases latest top hospitals list, adds COVID heroes -
-
-
-
-
Is your job performance being evaluated for the wrong factors? -
From the Society
Video
-
Critical care and COVID-19: Dr. Matt Aldrich -
Treatment options for COVID-19: Dr. Annie Luetkemeyer -
Managing the COVID-19 isolation floor at UCSF Medical Center -
-
